Chief Executive Officer
Dr. Flemming Ornskov, MD, MPH is Chief Executive Officer of Galderma since October 2019.
Dr. Flemming Ornskov, MD, MPH is the non-executive Chairman of Recordati S.p.A and Centogene, and a director at Waters Corporation.
Prior to joining Galderma, he served as Chief Executive Officer of Shire plc from 2013 to 2019. Before Shire, Flemming served as Chief Marketing Officer and Global Head, Strategic Marketing for General and Specialty Medicine at Bayer, Global President, Pharmaceuticals and OTC Bausch & Lomb Inc., first Chairman then CEO of Lifecycle Pharma A/S (now Veloxis), President and CEO of Ikaria Inc. and President of Ophthalmology at Novartis.
Flemming qualified as a Doctor of Medicine at the University of Copenhagen Medical School, gained a Master of Public Health (MPH) at Harvard University School of Public Health and an MBA from INSEAD.